Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-29T05:00:38.194Z Has data issue: false hasContentIssue false

22 - The Lymphatics: On the Route to Cancer Metastasis

from SYSTEMIC FACTORS

Published online by Cambridge University Press:  05 June 2012

Tara Karnezis
Affiliation:
Royal Melbourne Hospital, Australia
Ramin Shayan
Affiliation:
Royal Melbourne Hospital, Australia
Marc G. Achen
Affiliation:
Royal Melbourne Hospital, Australia
Steven A. Stacker
Affiliation:
Royal Melbourne Hospital, Australia
David Lyden
Affiliation:
Weill Cornell Medical College, New York
Danny R. Welch
Affiliation:
Weill Cornell Medical College, New York
Bethan Psaila
Affiliation:
Imperial College of Medicine, London
Get access

Summary

The blood vascular and lymphatic systems are necessary for the flux of gases, liquids, nutrients, signaling molecules, and cells among tissues and organs. These two highly branched, treelike networks are interconnected through the largest lymphatic vessel, the thoracic duct, which drains lymph, the protein-rich interstitial fluid, into the blood circulation. Both networks contribute to homeostasis of a healthy individual, and their malformation or dysfunction contributes to the pathogenesis of many diseases, such as cancer [1].

The lethality of cancer is associated primarily with metastasis – that is, the spread of cancer cells from the primary site to lymph nodes and to distant organs [2]. In principle, tumor cells can spread within the body by three main pathways: direct invasion of surrounding tissues, via the blood system to distant organs (hematogenous spread), or via the lymphatic system to the sentinel lymph node, distal lymph nodes, and distant organs (lymphogenous spread) (Figure 22.1).

Tumor cells induce the growth of new lymphatic vessels within and immediately around tumors and draining lymph nodes, enhancing immune cell trafficking to lymph nodes. Increased lymphatic vessel density in tumors is also associated with increased metastasis to lymph nodes [3]. The extent of lymph node metastasis is a major determinant for disease staging. Despite its clinical relevance, however, little is known about the mechanisms that govern spread via the lymphatic system.

Type
Chapter
Information
Cancer Metastasis
Biologic Basis and Therapeutics
, pp. 237 - 254
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, RH, Alitalo, K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 8:464–478.CrossRefGoogle ScholarPubMed
Plate, K (2001) From angiogenesis to lymphangiogenesis. Nat Med. 7:151–152.CrossRefGoogle ScholarPubMed
Hirakawa, S, Kodama, S et al. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 201:1089–1099.CrossRefGoogle ScholarPubMed
Joukov, V, Pajusola, K et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290–298.Google ScholarPubMed
Orlandini, M, Marconcini, L et al. (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA. 93:11675–11680.CrossRefGoogle ScholarPubMed
Achen, MG, Jeltsch, M et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc Natl Acad Sci USA. 95:548–553.CrossRefGoogle Scholar
Achen, MG, Stacker, SA (2008) Molecular control of lymphatic metastasis. Ann NY Acad Sci. 1131:225–234.CrossRefGoogle ScholarPubMed
Rusznyak, I, Foldi, M, Szabo, G, editors (1960) Lymphatics and lymph circulation. New York: Oxford.Google Scholar
Robinson, B (1907) Chapter 38 –The Pathologic Physiology of (I.) Tractus Lymphaticus, (II.) Lymph. Volume: The Abdominal and Pelvic Brain in Early American Manual Therapy.Google Scholar
Skobe, M, Detmar, M (2000) Structure, function, and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc. 5:14–19.CrossRefGoogle ScholarPubMed
Sabin, F (1902) On the origin and development of the lymphatic system from the veins and the development of lymph hearts and the thoracic duct in the pig. Am J Anat. 1:367–389.CrossRefGoogle Scholar
LeDran, H, Gataker, T et al. (1752) Traite des operations de chirurgie (English translation Gataker). London: C. Hitch, R. Dosley.Google Scholar
Kinmonth, JB (1972) The Lymphatics: Diseases, Lymphography, and Surgery. London: Edward Arnold.Google Scholar
Sherman, AI, Ter-Pogossian, M (1953) Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer. 6:1238–1240.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Cochran, AJ, Wen, DR et al. (1992) Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg. 16:214–221.CrossRefGoogle ScholarPubMed
Oliver, G, Detmar, M (2002) The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 16:773–783.CrossRefGoogle ScholarPubMed
Scavelli, C, Weber, E et al. (2004) Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat. 204:433–449.CrossRefGoogle ScholarPubMed
Saharinen, P, Petrova, TV (2004) Molecular regulation of lymphangiogenesis. Ann NY Acad Sci. 1014:76–87.CrossRefGoogle ScholarPubMed
Leak, LV (1976) The structure of lymphatic capillaries in lymph formation. Fed Proc. 35:1863–1871.Google ScholarPubMed
Baluk, P, Fuxe, J et al. (2007) Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 204:2349–2362.CrossRefGoogle ScholarPubMed
Veikkola, T, Lohela, M et al. (2003) Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB J. 17:2006–2013.CrossRefGoogle ScholarPubMed
He, Y, Rajantie, I et al. (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65:4739–4746.CrossRefGoogle ScholarPubMed
Hoshida, T, Isaka, N et al. (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 66:8065–8075.CrossRefGoogle ScholarPubMed
Oliver, G, Harvey, N (2002) A stepwise model of the development of lymphatic vasculature. Ann N Y Acad Sci. 979:159–165; discussion 188–196.CrossRefGoogle ScholarPubMed
Francois, M, Caprini, A et al. (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature. 456:643–647.CrossRefGoogle ScholarPubMed
Wigle, JT, Oliver, G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell. 98:769–778.CrossRefGoogle ScholarPubMed
Karkkainen, MJ, Haiko, P et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 5:74–80.CrossRefGoogle ScholarPubMed
Harvey, NL, Oliver, G (2004) Choose your fate: artery, vein or lymphatic vessel? Curr Opin Genet Dev. 14:499–505.CrossRefGoogle ScholarPubMed
Breiteneder-Geleff, S, Soleiman, A et al. (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 154:385–394.CrossRefGoogle ScholarPubMed
Jackson, DG, Prevo, R et al. (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 22:317–321.CrossRefGoogle ScholarPubMed
Sleeman, JP, Krishnan, J et al. (2001) Markers for the lymphatic endothelium: In search of the holy grail?Microsc Res Tech. 55:61–69.CrossRefGoogle ScholarPubMed
Veikkola, T, Jussila, L et al. (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20:1223–1231.CrossRefGoogle ScholarPubMed
Karpanen, T, Egeblad, M et al. (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61:1786–1790.Google ScholarPubMed
Mandriota, SJ, Jussila, L et al. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20:672–682.CrossRefGoogle ScholarPubMed
Skobe, M, Hawighorst, T et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 7:192–198.CrossRefGoogle ScholarPubMed
Stacker, SA, Caesar, C et al. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med. 7:186–191.CrossRefGoogle ScholarPubMed
Muller, WA, Weigl, SA et al. (1993) PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 178:449–460.CrossRefGoogle ScholarPubMed
Newman, PJ, Berndt, MC et al. (1990) PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 247:1219–1222.CrossRefGoogle ScholarPubMed
Nerlich, AG, Schleicher, E (1991) Identification of lymph and blood capillaries by immunohistochemical staining for various basement membrane components. Histochemistry. 96:449–453.CrossRefGoogle ScholarPubMed
de Waal, RM, Altena, MC et al. (1997) Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Pathol. 150:1951–1957.Google ScholarPubMed
Xu, T, Chen, D, Chen, J (2004). Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma. J Huazhong Univ Sci Technolog Med Sci. 24:596–598.Google ScholarPubMed
Kaipainen, A, Korhonen, J et al. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 92:3566–3570.CrossRefGoogle ScholarPubMed
Dumont, DJ, Jussila, L et al. (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 282:946–949.CrossRefGoogle ScholarPubMed
Partanen, TA, Arola, J et al. (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 14:2087–2096.CrossRefGoogle ScholarPubMed
Petrova, TV, Makinen, T et al. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21:4593–4599.CrossRefGoogle ScholarPubMed
Hirakawa, S, Hong, YK et al. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol. 162:575–586.CrossRefGoogle ScholarPubMed
Kriehuber, E, Breiteneder-Geleff, S et al. (2001) Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. JEM. 194:797–808.CrossRefGoogle ScholarPubMed
Makinen, T, Jussila, L et al. (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 7:199–205.CrossRefGoogle ScholarPubMed
Hong, YK, Harvey, N et al. (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn. 225:351–357.CrossRefGoogle ScholarPubMed
Petrova, TV, Makinen, T et al. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21:4593–4599.CrossRefGoogle ScholarPubMed
Banerji, S, Ni, J et al. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 144:789–801.CrossRefGoogle ScholarPubMed
Makinen, T, Adams, RH et al. (2005) PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19:397–410.CrossRefGoogle ScholarPubMed
Scavelli, C, Vacca, A et al. (2004) Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia. 18:1054–1058.CrossRefGoogle ScholarPubMed
Johnston, MG, Walker, MA (1984) Lymphatic endothelial and smooth-muscle cells in tissue culture. In Vitro. 20:566–572.CrossRefGoogle ScholarPubMed
Pepper, MS (2001) Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res. 7:462–468.Google ScholarPubMed
Pepper, MS, Skobe, M (2003) Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol. 163:209–213.CrossRefGoogle ScholarPubMed
Makinen, T, Veikkola, T et al. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:4762–4773.CrossRefGoogle ScholarPubMed
Podgrabinska, S, Braun, P et al. (2002) Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA. 99:16069–16074.CrossRefGoogle ScholarPubMed
Partanen, TA, Alitalo, K, Miettinen, M (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer. 86:2406–2412.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Durr, E, Yu, J et al. (2004) Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol. 22:985–992.CrossRefGoogle ScholarPubMed
Wick, N, Saharinen, P et al. (2007) Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics. 28:179–192.CrossRefGoogle ScholarPubMed
Podgrabinska, S, Braun, P et al. (2002) Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA. 99:16069–16074.CrossRefGoogle ScholarPubMed
St Croix, B, Rago, C et al. (2000) Genes Expressed in Human Tumor Endothelium. Science. 289:1197–1202.CrossRefGoogle ScholarPubMed
Clasper, S, Royston, D et al. (2008) A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res. 68:7293–7303.CrossRefGoogle ScholarPubMed
Iyer, S, Leonidas, DD et al. (2001) The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 Å resolution. J Biol Chem. 276:12153–12161.CrossRefGoogle Scholar
Muller, YA, Li, B et al. (1997) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA. 94:7192–7197.CrossRefGoogle ScholarPubMed
Iyer, S, Scotney, PD et al. (2006) Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding. J Mol Biol. 359:76–85.CrossRefGoogle ScholarPubMed
Olsson, AK, Dimberg, A et al. (2006) VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol. 7:359–371.CrossRefGoogle ScholarPubMed
Jussila, L, Alitalo, K (2002) Vascular growth factors and lymphangiogenesis. Physiol Rev. 82:673–700.CrossRefGoogle ScholarPubMed
Stacker, SA, Baldwin, ME, Achen, MG (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 16:922–934.CrossRefGoogle ScholarPubMed
Oh, SJ, Jeltsch, MM et al. (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Devel Biol. 188:96–109.CrossRefGoogle ScholarPubMed
Jeltsch, M, Kaipainen, A et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1423–1425.CrossRefGoogle ScholarPubMed
Joukov, V, Kumar, V et al. (1998) A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J of Biol Chem. 273:6599–6602.CrossRefGoogle ScholarPubMed
Ristimaki, A, Narko, K et al. (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem. 273:8413–8418.CrossRefGoogle ScholarPubMed
Enholm, B, Jussila, L et al. (1998) Vascular endothelial growth factor-C: a growth factor for lymphatic and blood vascular endothelial cells. Trends Cardiovasc Med. 8:292–297.CrossRefGoogle ScholarPubMed
Lee, AHS, Happerfield, LC et al. (1997) Angiogenesis and inflammation in ductal carcinoma in situ of the breast. J Pathol. 181:200–206.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Ny, A, Koch, M et al. (2005) A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat Med. 11:998–1004.CrossRefGoogle ScholarPubMed
Ny, A, Autiero, M, Carmeliet, P (2006) Zebrafish and Xenopus tadpoles: small animal models to study angiogenesis and lymphangiogenesis. Exp Cell Res. 312:684–693.CrossRefGoogle ScholarPubMed
Yaniv, K, Isogai, S et al. (2006) Live imaging of lymphatic development in the zebrafish. Nat Med. 12:711–716.CrossRefGoogle ScholarPubMed
Kuchler, AM, Gjini, E et al. (2006) Development of the zebrafish lymphatic system requires vegfc signaling. Curr Biol. 16:1244–1248.CrossRefGoogle ScholarPubMed
Tammela, T, Zarkada, G et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 454:656–660.CrossRefGoogle ScholarPubMed
Joukov, V, Sorsa, T et al. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16:3898–3911.CrossRefGoogle ScholarPubMed
Cao, Y, Linden, P et al. (1998) Vascular endothelial growth factor C induces angiogenesis in vivoProc Natl Acad Sci USA. 95:14389–14394.CrossRefGoogle ScholarPubMed
Witzenbichler, B, Asahara, T et al. (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol. 153:381–394.CrossRefGoogle ScholarPubMed
Oh, SJ, Jeltsch, MM et al. (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol. 188:96–109.CrossRefGoogle ScholarPubMed
Saaristo, A, Veikkola, T et al. (2002) Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16:1041–1049.CrossRefGoogle ScholarPubMed
Achen, MG, Jeltsch, M et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA. 95:548–553.CrossRefGoogle Scholar
Stacker, SA, Stenvers, K et al. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem. 274:32127–32136.CrossRefGoogle ScholarPubMed
McColl, BK, Baldwin, ME et al. (2003) Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med. 198:863–868.CrossRefGoogle ScholarPubMed
McColl, BK, Paavonen, K et al. (2007) Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 21:1088–1098.CrossRefGoogle ScholarPubMed
Khatib, AM, Siegfried, G et al. (2002) Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am J Pathol. 160:1921–1935.CrossRefGoogle ScholarPubMed
Siegfried, G, Basak, A et al. (2003) The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest. 111:1723–1732.CrossRefGoogle ScholarPubMed
Baldwin, ME, Catimel, B et al. (2001) The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man. J Biol Chem. 276:19166–19171.CrossRefGoogle ScholarPubMed
Baldwin, ME, Halford, MM et al. (2005) Vascular endothelial growth factor d is dispensable for development of the lymphatic system. Mol Cell Biol. 25:2441–2449.CrossRefGoogle ScholarPubMed
Ny, A, Koch, M, Vandevelde, W et al. (2008) Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood. 112:1740–1749.CrossRefGoogle ScholarPubMed
Makinen, T, Norrmen, C, Petrova, TV (2007) Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci. 64:1915–1929.CrossRefGoogle ScholarPubMed
Byzova, TV, Goldman, CK et al. (2002) Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood. 99:4434–4442.CrossRefGoogle ScholarPubMed
Rissanen, TT, Markkanen, JE et al. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 92:1098–1106.CrossRefGoogle ScholarPubMed
Achen, MG, Williams, RA et al. (2002) The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. Growth Factors. 20:99–107.CrossRefGoogle Scholar
Aprelikova, O, Pajusola, K et al. (1992) FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res. 52:746–748.Google ScholarPubMed
Borg, JP, deLapeyriere, O et al. (1995) Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene. 10:973–984.Google ScholarPubMed
Dixelius, J, Makinen, T et al. (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem. 278:40973–40979.CrossRefGoogle ScholarPubMed
Yuan, L, Moyon, D et al. (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development. 129:4797–4806.Google ScholarPubMed
Yokoyama, Y, Charnock-Jones, DS et al. (2003) Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer. 88:237–244.CrossRefGoogle ScholarPubMed
Zeng, Y, Opeskin, K et al. (2004) Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res. 10:5137–5144.CrossRefGoogle ScholarPubMed
Kubo, H, Fujiwara, T et al. (2000) Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood. 96:546–553.Google ScholarPubMed
Ferrara, N, Gerber, HP, LeCouter, J (2003) The biology of VEGF and its receptors. Nat Med. 9:669–676.CrossRefGoogle ScholarPubMed
Bjorndahl, MA, Cao, R et al. (2005) Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65:9261–9268.CrossRefGoogle ScholarPubMed
Whitehurst, B, Flister, MJ et al. (2007) Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. Int J Cancer. 121:2181–2191.CrossRefGoogle Scholar
Gannon, G, Mandriota, SJ et al. (2002) Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis. Cancer Res. 62:603–608.Google Scholar
Kajiya, K, Hirakawa, S et al. (2005) Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 24:2885–2895.CrossRefGoogle ScholarPubMed
Cao, R, Bjorndahl, MA et al. (2006) Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood. 107:3531–3536.CrossRefGoogle ScholarPubMed
Cao, R, Bjorndahl, MA et al. (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 6:333–345.CrossRefGoogle ScholarPubMed
Bjorndahl, M, Cao, R et al. (2005) Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci USA. 102:15593–15598.CrossRefGoogle ScholarPubMed
Tang, Y, Zhang, D et al. (2003) Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res. 63:1166–1171.Google ScholarPubMed
Mita, K, Nakahara, M, Usui, T (2000) Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients. Int J Urol. 7:321–329.CrossRefGoogle ScholarPubMed
Kubo, H, Cao, R et al. (2002) Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA. 99:8868–8873.CrossRefGoogle ScholarPubMed
Koukourakis, MI, Giatromanolaki, A et al. (2005) LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol. 58:202–206.CrossRefGoogle ScholarPubMed
Padera, TP, Kadambi, A et al. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 296:1883–1886.CrossRefGoogle ScholarPubMed
Cassella, M, Skobe, M (2002) Lymphatic vessel activation in cancer. Ann NY Acad Sci. 979:120–130.CrossRefGoogle Scholar
Stacker, SA, Achen, MG et al. (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2:573–583.CrossRefGoogle ScholarPubMed
Alitalo, K, Carmeliet, P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 1:219–227.CrossRefGoogle ScholarPubMed
Schietroma, C, Cianfarani, F et al. (2003) Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer. 98:789–797.CrossRefGoogle ScholarPubMed
Goydos, JS, Gorski, DH (2003) Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Cancer Res. 9:5962–5967.Google ScholarPubMed
Niki, T, Iba, S et al. (2000) Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res. 6:2431–2439.Google Scholar
O-charoenrat, P, Rhys-Evans, P, Eccles, SA (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer. 92:556–568.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Tanaka, K, Kurebayashi, J et al. (2002) Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues. Surgery Today. 32:761–768.CrossRefGoogle ScholarPubMed
Arinaga, M, Noguchi, T et al. (2003) Clinical significance of vascular, endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer. 97:457–464.CrossRefGoogle Scholar
Ichikura, T, Tomimatsu, S et al. (2001) Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol. 78:132–137.CrossRefGoogle ScholarPubMed
Kabashima, A, Maehara, Y et al. (2001) Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology. 60:146–150.CrossRefGoogle ScholarPubMed
Amioka, T, Kitadai, Y et al. (2002) Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer. 38:1413–1419.CrossRefGoogle ScholarPubMed
Kitadai, Y, Kodama, M et al. (2005) Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer. 115:388–392.CrossRefGoogle ScholarPubMed
Nakamura, Y, Yasuoka, H et al. (2003) Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Clin Cancer Res. 9:5313–5317.Google ScholarPubMed
Hirai, M, Nakagawara, A et al. (2001) Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol. 80:181–188.CrossRefGoogle ScholarPubMed
Saad, RS, Kordunsky, L et al. (2006) Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol. 19:1317–1323.CrossRefGoogle ScholarPubMed
White, JD, Hewett, PW et al. (2002) Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res. 62:1669–1675.Google ScholarPubMed
Kaio, E, Tanaka, S et al. (2003) Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology. 64:61–73.CrossRefGoogle ScholarPubMed
Kopfstein, L, Veikkola, T et al. (2007) Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol. 170:1348–1361.CrossRefGoogle ScholarPubMed
He, Y, Kozaki, K et al. (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst. 94:819–825.CrossRefGoogle ScholarPubMed
Chang, YS, Munn, LL et al. (2000) Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. Microvasc Res. 59:265–277.CrossRefGoogle ScholarPubMed
Achen, MG, McColl, BK, Stacker, SA (2005) Focus on lymphangiogenesis in tumor metastasis. Cancer Cell. 7:121–127.CrossRefGoogle ScholarPubMed
Kabbinavar, F, Hurwitz, HI et al. (2003) Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 21:60–65.CrossRefGoogle ScholarPubMed
Kabbinavar, FF, Hambleton, J et al. (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol. 23:3706–3712.CrossRefGoogle ScholarPubMed
Achen, MG, Roufail, S et al. (2000) Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3. Eur J Biochem. 267:2505–2515.CrossRefGoogle ScholarPubMed
Lin, J, Lalani, AS et al. (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res. 65:6901–6909.CrossRefGoogle ScholarPubMed
Siegfried, G, Basak, A et al. (2003) The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest. 111:1723–1732.CrossRefGoogle ScholarPubMed
Wood, JM, Bold, G et al. (2000) PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 60:2178–2189.Google ScholarPubMed
Arora, A, Scholar, EM (2005) Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther. 315:971–979.CrossRefGoogle ScholarPubMed
Staehler, M, Haseke, N et al. (2006) Therapy strategies for advanced renal cell carcinoma. Urologe A. 45:99–112.CrossRefGoogle ScholarPubMed
Wood, JM, Bold, G et al. (2000) PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Research. 60:2178–2189.Google ScholarPubMed
Ruggeri, B, Singh, J et al. (2003) CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Cancer Research. 63:5978–5991.Google ScholarPubMed
Wilhelm, SM, Carter, C et al. (2004) BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Research. 64:7099–7109.CrossRefGoogle ScholarPubMed
Drevs, J, Zirrgiebel, U et al. (2005) Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. Ann Oncol. 16:558–565.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×